Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain [Phase 3]
A Phase 3 study of COV795 in osteoarthritis and chronic low back pain has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects [Phase 2]
Phase 2 study evaluating SM04690 injected into the knee for osteoarthritis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee [NA]
Clinical trial update on the safety and effectiveness of Monovisc injection for knee osteoarthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain [Phase 3]
Phase 3 double-blind trial evaluating controlled release OROS hydromorphone versus placebo in chronic osteoarthritis pain; trial completed w…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) [NA]
Clinical trial update for the Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) completed with posted resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Post-market surveillance study for the HYPERION Hip Endoprosthesis System has been terminated; results were posted in 2020.
-
FDA approval · 2020-08-11FDA Approved: DICLOFENAC SODIUM — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for diclofenac sodium topical gel, 1%, from BluePoint Laboratories. The action pertains to a gen…
-
CLINICAL_TRIALS research · 2020-07-30Clinical Trial Update: Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement [Phase 3]
Long-term observational study update following tanezumab studies in subjects undergoing total knee, hip, or shoulder replacement for osteoar…
-
FDA approval · 2020-07-28FDA Approved: NAPROXEN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Naproxen from Glenmark Pharmaceuticals to update the labeling for the generic product under the …
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Risk Factor Control Before Orthopedic Surgery [Phase 4]
Phase 4 clinical trial on risk factor control before orthopedic surgery was terminated; results timeline posted.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale [Phase 2]
Phase 2 pilot study assessing a novel osteoarthritis stiffness scale and treatment responsiveness.
-
FDA approval · 2020-06-01FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' MELOXICAM as an original-application generic meloxicam; the drug is indicated for relief of pain and inf…
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Tranexamic Acid in Knee Joint Surgery [Phase 4]
Phase 4 clinical trial update for tranexamic acid in knee joint surgery for osteoarthritis; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: A Study of LY2828360 in Patients With Osteoarthritic Knee Pain [Phase 2]
Phase 2 clinical trial of LY2828360 in osteoarthritis of the knee has completed with results posted.
-
FDA approval · 2020-05-08FDA Approved: IBUPROFEN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's ibuprofen generic under Original Application (ANDA213794). The product is a generic version of ibupr…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Topical Tranexamic Acid (TXA) in Joint Arthroplasty [Phase 4]
Phase 4 trial evaluating topical tranexamic acid in joint arthroplasty has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty [NA]
A completed clinical trial comparing ATTUNE single-use vs reusable instrumentation in primary total knee arthroplasty; results posted in 202…
-
FDA approval · 2020-04-01FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for Publix Super Markets Inc's arthritis pain reliever containing diclofenac sodium under an ANDA.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty [NA]
Completed clinical trial evaluating liposomal bupivacaine for pain control after shoulder arthroplasty; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Synvisc-One for Younger, Active Patients With Osteoarthritis [NA]
Clinical trial update for Synvisc-One in younger, active patients with osteoarthritis; trial completed with results posted.
-
FDA approval · 2020-03-19FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a suppleme…
-
FDA approval · 2020-03-06FDA Approved: CELECOXIB — Original Application (Chartwell RX, LLC)
FDA approved the original generic application for celecoxib (Celecoxib) by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Blood Loss Reduction After Total Knee Arthroplasty. Comparison Topical Tranexamic Acid vs Platelet Rich Plasma [Phase 3]
Phase 3 trial comparing topical tranexamic acid to platelet-rich plasma for blood loss reduction after total knee arthroplasty in osteoarthr…
-
FDA approval · 2020-02-25FDA Approved: CELECOXIB — Original Application (EPIC PHARMA, LLC)
FDA approved the Original Application (ANDA) for a generic Celecoxib product from Epic Pharma, LLC, enabling its marketing as a COX-2 inhibi…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty [Phase 1]
Phase 1 trial characterizing diclofenac gel exposure in knee tissue and plasma in osteoarthritis patients undergoing arthroplasty; study com…